Please provide your email address to receive an email when new articles are posted on . Using data from the US Renal Data System, researchers identified 74,194 Medicare-eligible patients who initiated ...
Dialysis patients with central venous catheters more likely to contract bloodstream infections Infection rates and other dialysis events were highest among patients with a central venous catheter as ...
Although consensus guidelines promote the use of arteriovenous fistulas for vascular access, the vast majority of US patients initiate haemodialysis using a central venous catheter. Malas et al.
Hispanic, Latino, and non-Hispanic Black Americans on dialysis for end-stage kidney disease have a higher risk of developing life-threatening bloodstream infections, a new report says. And those ...
Central venous stenosis is a significant clinical challenge affecting haemodialysis patients. It is predominantly associated with previous central venous catheter placements and repeated vascular ...
Please provide your email address to receive an email when new articles are posted on . Good vascular access continues to be a cornerstone of optimal hemodialysis (HD) for patients with end-stage ...
Suboptimal dialysis initiation, typically defined as dialysis initiation during a hospitalization and/or with a central venous catheter, is common among patients with advanced chronic kidney disease ...
WAYNE, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the release of the Arrow™ ErgoPack™ Complete Kits ...
Zacks Investment Research on MSN
CorMedix banks on DefenCath sales in Q4 as Melinta adds upside
The majority of CorMedix’s CRMD revenues come from its lead product, DefenCath, which is approved as the first and only antimicrobial catheter lock solution in the United States. The product is ...
Bluegrass Vascular nabbed a CE mark for its "inside-out" central venous catheter last summer. Now, the company is tapping Merit Medical to “streamline” the distribution of the device in Europe. "We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results